Literature DB >> 2900655

Extracellular cAMP formation from host cell ATP by Bordetella pertussis adenylate cyclase.

F Gentile1, A Raptis, L G Knipling, J Wolff.   

Abstract

The effect of exogenously added adenylate cyclase from Bordetella pertussis (strain 114) has been investigated in Y-1 mouse adrenal tumor, chinese hamster ovary (CHO) and several other cells. A partially purified adenylate cyclase was found not to enter cells but, nevertheless, produced large amounts of cAMP in the medium. We could show that this resulted from release of ATP (and not larger molecules). The ATP released by the cells could be (1) directly measured and was replenished after each change of medium; (2) was reciprocally related to the cAMP produced; and (3) was competed for by ATPases present in added serum or by hexokinase and, less effectively, by exoenzymes on the cell surface. The extent of ATP leakage varied widely between different cell lines, being marked in CHO and Y-1 adrenal cells but negligible in transformed lymphocyte lines. The uncertainty of the origin of cAMP found in media of cultured cells requires separate analysis of cell and medium cAMP and an assessment of ATP leakage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900655     DOI: 10.1016/0167-4889(88)90162-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

2.  Modulation of invasiveness and catalytic activity of Bordetella pertussis adenylate cyclase by polycations.

Authors:  A Raptis; L G Knipling; F Gentile; J Wolff
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  Yersinia pestis YopM: thrombin binding and overexpression.

Authors:  B S Reisner; S C Straley
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

4.  A Simple Luminescent Adenylate-Cyclase Functional Assay for Evaluation of Bacillus anthracis Edema Factor Activity.

Authors:  Ma'ayan Israeli; Shahar Rotem; Uri Elia; Erez Bar-Haim; Ofer Cohen; Theodor Chitlaru
Journal:  Toxins (Basel)       Date:  2016-08-18       Impact factor: 4.546

Review 5.  New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.

Authors:  Manar Mohammed El Tabaa; Maram Mohammed El Tabaa
Journal:  Eur J Pharmacol       Date:  2020-10-01       Impact factor: 4.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.